Bone marrow and peripheral blood involvement in mantle cell lymphoma

P. L. Cohen, P. J. Kurtin, K. A. Donovan, C. A. Hanson

Research output: Contribution to journalArticle

93 Citations (Scopus)

Abstract

The peripheral blood smears, bone marrow aspirates and biopsies of 46 patients with mantle cell lymphoma were reviewed. The diagnosis of mantle cell lymphoma was established in all cases on extramedullary tissue samples using standard morphologic, phenotypic and molecular genetic criteria. 27/35 patients (77%) had circulating lymphoma cells (median 20% of all circulating white blood cells: range 5-90%) identified by morphology at some point during the course of their disease. No statistical difference in survival was detected in patients with or without peripheral blood involvement. Lymphoma was identified in bone marrow aspirate specimens from 33/40 patients (83%) and in bone marrow biopsy specimens from 39/43 patients (91%). The pattern of marrow biopsy involvement was nodular (31 cases; 82%), interstitial (19 cases; 50%), paratrabecular (17 cases, 45%) and diffuse (12 cases; 32%). Although the median survival of patients with ≤ 50% bone marrow involvement was 13 months, and the median survival of patients with ≤ 50% was 49 months, no statistically significant differences between these small subgroups were observed. Mantle cell lymphoma frequently involves the peripheral blood and bone marrow. Its appearance is distinctive but variable, and immunophenotypic studies as well as morphologic confirmation by a biopsy of tissue other than bone marrow is still required for diagnosis.

Original languageEnglish (US)
Pages (from-to)302-310
Number of pages9
JournalBritish Journal of Haematology
Volume101
Issue number2
DOIs
StatePublished - 1998

Fingerprint

Mantle-Cell Lymphoma
Bone Marrow
Biopsy
Survival
Lymphoma
Molecular Biology
Leukocytes

Keywords

  • Bcl-1
  • Bone marrow
  • Mantle cell lyphoma
  • Peripheral blood
  • Polymerase chain reaction

ASJC Scopus subject areas

  • Hematology

Cite this

Bone marrow and peripheral blood involvement in mantle cell lymphoma. / Cohen, P. L.; Kurtin, P. J.; Donovan, K. A.; Hanson, C. A.

In: British Journal of Haematology, Vol. 101, No. 2, 1998, p. 302-310.

Research output: Contribution to journalArticle

Cohen, P. L. ; Kurtin, P. J. ; Donovan, K. A. ; Hanson, C. A. / Bone marrow and peripheral blood involvement in mantle cell lymphoma. In: British Journal of Haematology. 1998 ; Vol. 101, No. 2. pp. 302-310.
@article{16d8d502cf1c44c5ac1d58d1052ea8c7,
title = "Bone marrow and peripheral blood involvement in mantle cell lymphoma",
abstract = "The peripheral blood smears, bone marrow aspirates and biopsies of 46 patients with mantle cell lymphoma were reviewed. The diagnosis of mantle cell lymphoma was established in all cases on extramedullary tissue samples using standard morphologic, phenotypic and molecular genetic criteria. 27/35 patients (77{\%}) had circulating lymphoma cells (median 20{\%} of all circulating white blood cells: range 5-90{\%}) identified by morphology at some point during the course of their disease. No statistical difference in survival was detected in patients with or without peripheral blood involvement. Lymphoma was identified in bone marrow aspirate specimens from 33/40 patients (83{\%}) and in bone marrow biopsy specimens from 39/43 patients (91{\%}). The pattern of marrow biopsy involvement was nodular (31 cases; 82{\%}), interstitial (19 cases; 50{\%}), paratrabecular (17 cases, 45{\%}) and diffuse (12 cases; 32{\%}). Although the median survival of patients with ≤ 50{\%} bone marrow involvement was 13 months, and the median survival of patients with ≤ 50{\%} was 49 months, no statistically significant differences between these small subgroups were observed. Mantle cell lymphoma frequently involves the peripheral blood and bone marrow. Its appearance is distinctive but variable, and immunophenotypic studies as well as morphologic confirmation by a biopsy of tissue other than bone marrow is still required for diagnosis.",
keywords = "Bcl-1, Bone marrow, Mantle cell lyphoma, Peripheral blood, Polymerase chain reaction",
author = "Cohen, {P. L.} and Kurtin, {P. J.} and Donovan, {K. A.} and Hanson, {C. A.}",
year = "1998",
doi = "10.1046/j.1365-2141.1998.00684.x",
language = "English (US)",
volume = "101",
pages = "302--310",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Bone marrow and peripheral blood involvement in mantle cell lymphoma

AU - Cohen, P. L.

AU - Kurtin, P. J.

AU - Donovan, K. A.

AU - Hanson, C. A.

PY - 1998

Y1 - 1998

N2 - The peripheral blood smears, bone marrow aspirates and biopsies of 46 patients with mantle cell lymphoma were reviewed. The diagnosis of mantle cell lymphoma was established in all cases on extramedullary tissue samples using standard morphologic, phenotypic and molecular genetic criteria. 27/35 patients (77%) had circulating lymphoma cells (median 20% of all circulating white blood cells: range 5-90%) identified by morphology at some point during the course of their disease. No statistical difference in survival was detected in patients with or without peripheral blood involvement. Lymphoma was identified in bone marrow aspirate specimens from 33/40 patients (83%) and in bone marrow biopsy specimens from 39/43 patients (91%). The pattern of marrow biopsy involvement was nodular (31 cases; 82%), interstitial (19 cases; 50%), paratrabecular (17 cases, 45%) and diffuse (12 cases; 32%). Although the median survival of patients with ≤ 50% bone marrow involvement was 13 months, and the median survival of patients with ≤ 50% was 49 months, no statistically significant differences between these small subgroups were observed. Mantle cell lymphoma frequently involves the peripheral blood and bone marrow. Its appearance is distinctive but variable, and immunophenotypic studies as well as morphologic confirmation by a biopsy of tissue other than bone marrow is still required for diagnosis.

AB - The peripheral blood smears, bone marrow aspirates and biopsies of 46 patients with mantle cell lymphoma were reviewed. The diagnosis of mantle cell lymphoma was established in all cases on extramedullary tissue samples using standard morphologic, phenotypic and molecular genetic criteria. 27/35 patients (77%) had circulating lymphoma cells (median 20% of all circulating white blood cells: range 5-90%) identified by morphology at some point during the course of their disease. No statistical difference in survival was detected in patients with or without peripheral blood involvement. Lymphoma was identified in bone marrow aspirate specimens from 33/40 patients (83%) and in bone marrow biopsy specimens from 39/43 patients (91%). The pattern of marrow biopsy involvement was nodular (31 cases; 82%), interstitial (19 cases; 50%), paratrabecular (17 cases, 45%) and diffuse (12 cases; 32%). Although the median survival of patients with ≤ 50% bone marrow involvement was 13 months, and the median survival of patients with ≤ 50% was 49 months, no statistically significant differences between these small subgroups were observed. Mantle cell lymphoma frequently involves the peripheral blood and bone marrow. Its appearance is distinctive but variable, and immunophenotypic studies as well as morphologic confirmation by a biopsy of tissue other than bone marrow is still required for diagnosis.

KW - Bcl-1

KW - Bone marrow

KW - Mantle cell lyphoma

KW - Peripheral blood

KW - Polymerase chain reaction

UR - http://www.scopus.com/inward/record.url?scp=0031840279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031840279&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2141.1998.00684.x

DO - 10.1046/j.1365-2141.1998.00684.x

M3 - Article

C2 - 9609526

AN - SCOPUS:0031840279

VL - 101

SP - 302

EP - 310

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 2

ER -